Major Depressive Episode Clinical Trial
Official title:
Study of Functional Networks in Resting fMRI as Biomarkers of Monopolar or Bipolar Depression
The primary purpose is to compare with resting fMRI the functional networks of rest (RTS) in
unipolar depression and in bipolar depression.
Hypothesis : the main objective of this work is to compare with the rest fMRI the Rest
Functional Networks (RFN) in the unipolar depression and in the bipolar depression in order
to identify specific biomarkers for each affection. The general hypothesis of this work is
that intra- and inter RFN connectivity is different between bipolar patients and unipolar
patients. Specifically the investigators assume that connectivity within the default mode
network (including ventral mediofrontal cortex, subgenual cingulate cortex, inferior parietal
cortex, posterior cingulate cortex) will be increased in unipolar patients compared to
bipolar patients.
Study hypothesis:
The investigators assume that connectivity within the DMR will be increased in unipolar
patients compared to bipolar patients. Similarly the investigators assume, in agreement with
the results of our studies using N-Back (Harvey et al, 2005) and studies in self reference
process in the unipolar depression (Grimm et al, 2009; and Lemogne al, 2009) that the DMR and
frontoparietal networks connectivity (intraparietal cortex and dorsolateral prefrontal
cortex) will be unusually positive in unipolar patients compared to bipolar patients.
Methods:
Transversal, multicenter, comparative study evaluating unipolar and bipolar patients in
depressive phase and controls group without psychiatric disorders. The study involves one
single assessment with fMRI, which is used to characterize a mono or bipolar major MDE. The
question is not to predict subsequent progression towards a unipolar or bipolar disorder.
Primary outcome :
Comparison of unipolar and bipolar depressed patients in depressive acute phase and control
subjects with fMRI resting task and an itself reference task and a diffusion tensor sequence.
Patients will be evaluated clinically by: the MADRS, the YMRS, the BDRS, the Mathys, the
SCID.
Secondary outcome:
verifying the RFR functional integrity in bipolar depression or unipolar by comparing the
brain activity patterns of depressed patients than the control group;
Experimental arm: patient with bipolar disorder type I or II and patient with unipolar
disorder Control arm: subjects without psychiatric disorders assessed by the SCID Number of
patients per arm : 40 Total number of patients : 123 Duration : inclusions 3 years. Duration
of inclusion per patient : 16 days Number of participating centres : 4 Statistical analyses:
fMRI data analysis strategy
The primary criterion is the variation of BOLD signal during resting state and during
self-referential processing task in both groups of depressed patients compared to control
group. Functional connectivity within and between DMN (default mode network), CEN (central
executive network) and SN (salience network) will be tested using a multivariate approach,
independent component analysis (ICA). This analysis simultaneously decomposes group fMRI data
into modes describing variations across space, time per subject to identify independent
functional spatial maps corresponding to coherent brain functional networks.
A between-group analysis of variance (ANOVA) will be performed to assess the difference of
functional connectivity within and between DMN, CEN and SN comprising a between factor group
(unipolar, bipolar, controls) for resting state data and data from the self-referential task.
Correlations:
Correlations will be explored between fMRI parameters (in default mode and central executive
network) and clinical criteria (e.g scores in MATTIS, MADRSn, YMRS).
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03256162 -
Ketamine as an Adjunctive Therapy for Major Depression
|
Phase 1 | |
Completed |
NCT01944293 -
Ketamine for Suicidality in Bipolar Depression
|
Phase 1/Phase 2 | |
Recruiting |
NCT01441505 -
A Study of Ketamine as an Antidepressant
|
Phase 2 | |
Active, not recruiting |
NCT03487926 -
Microglial Activation in Inflammatory Bowel Disease
|
||
Recruiting |
NCT04939649 -
Ketamine as an Adjunctive Therapy for Major Depression (2)
|
Phase 3 | |
Recruiting |
NCT05028738 -
Patient-oriented Randomized Pragmatic Feasibility Trial With rTMS in Depression and Anxiety
|
N/A | |
Recruiting |
NCT03646058 -
Add-on Buprenorphine at Analgesic Doses for the Treatment of Severe Suicidal Ideas During a Major Depressive Episode
|
Phase 3 | |
Not yet recruiting |
NCT06117397 -
A Text Messaging Intervention to Reduce Perinatal Depression Risk
|
N/A | |
Completed |
NCT03735576 -
Cognitive Behavioural Therapy for the Treatment of Late Life Depression
|
N/A | |
Recruiting |
NCT04999553 -
Left vs. Right Non-Inferiority Trial
|
N/A | |
Completed |
NCT03716869 -
Universal vs. Targeted School Screening for Adolescent Major Depressive Disorder
|
N/A | |
Recruiting |
NCT02824081 -
Neuroinflammation, Serotonin, Impulsivity and Suicide
|
N/A | |
Terminated |
NCT01099592 -
Antidepressants to Promote Recovery of Cardiac Patients Suffering From Depression
|
Phase 4 | |
Completed |
NCT03752853 -
Stress Systems and Psychotherapy in Depression
|
N/A | |
Recruiting |
NCT04480918 -
University of Iowa Interventional Psychiatry Service Patient Registry
|
||
Recruiting |
NCT04130958 -
Circuit-Based Approach to Suicide: Biomarkers, Predictors, and Novel Therapeutics
|
N/A | |
Completed |
NCT03190772 -
The Role of Expectations in the Pharmacological Treatment of Depression - An Experimental Investigation
|
N/A | |
Recruiting |
NCT04832750 -
Depression-Reduction by Accelerated Personalized NeuroModulation and Its Effects on Sleep
|
||
Terminated |
NCT02839798 -
NeoSync TMS Treatment for Bipolar I Depression
|
Phase 2 | |
Completed |
NCT00852592 -
Light Therapy for Bipolar Disorder. Efficacy of Light Therapy for Bipolar Depression: A Randomized Controlled Trial
|
Phase 3 |